204 related articles for article (PubMed ID: 20141169)
1. Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease.
Sabens EA; Distler AM; Mieyal JJ
Biochemistry; 2010 Mar; 49(12):2715-24. PubMed ID: 20141169
[TBL] [Abstract][Full Text] [Related]
2. Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease.
Liedhegner EA; Steller KM; Mieyal JJ
Chem Res Toxicol; 2011 Oct; 24(10):1644-52. PubMed ID: 21815648
[TBL] [Abstract][Full Text] [Related]
3. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
4. Methylglyoxal causes dysfunction of thioredoxin and thioredoxin reductase in endothelial cells.
Tatsunami R; Oba T; Takahashi K; Tampo Y
J Pharmacol Sci; 2009 Dec; 111(4):426-32. PubMed ID: 19966511
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of the thioredoxin and glutaredoxin systems in dopamine-induced cell death.
Arodin L; Miranda-Vizuete A; Swoboda P; Fernandes AP
Free Radic Biol Med; 2014 Aug; 73():328-36. PubMed ID: 24863694
[TBL] [Abstract][Full Text] [Related]
7. Impaired cross-talk between the thioredoxin and glutathione systems is related to ASK-1 mediated apoptosis in neuronal cells exposed to mercury.
Branco V; Coppo L; Solá S; Lu J; Rodrigues CMP; Holmgren A; Carvalho C
Redox Biol; 2017 Oct; 13():278-287. PubMed ID: 28600984
[TBL] [Abstract][Full Text] [Related]
8. Levodopa: effect on cell death and the natural history of Parkinson's disease.
Olanow CW
Mov Disord; 2015 Jan; 30(1):37-44. PubMed ID: 25502620
[TBL] [Abstract][Full Text] [Related]
9. Kinetic characterization of wild-type and mutant human thioredoxin glutathione reductase defines its reaction and regulatory mechanisms.
Brandstaedter C; Fritz-Wolf K; Weder S; Fischer M; Hecker B; Rahlfs S; Becker K
FEBS J; 2018 Feb; 285(3):542-558. PubMed ID: 29222842
[TBL] [Abstract][Full Text] [Related]
10. Levodopa (L-DOPA) attenuates endoplasmic reticulum stress response and cell death signaling through DRD2 in SH-SY5Y neuronal cells under α-synuclein-induced toxicity.
Song J; Kim BC; Nguyen DT; Samidurai M; Choi SM
Neuroscience; 2017 Sep; 358():336-348. PubMed ID: 28687316
[TBL] [Abstract][Full Text] [Related]
11. Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states.
Allen GF; Ullah Y; Hargreaves IP; Land JM; Heales SJ
Neurochem Int; 2013 Apr; 62(5):684-94. PubMed ID: 23261515
[TBL] [Abstract][Full Text] [Related]
12. Glutathione and Glutaredoxin-Key Players in Cellular Redox Homeostasis and Signaling.
Chai YC; Mieyal JJ
Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627548
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl-L-methionyl-L-Dopa-methyl ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity.
Minelli A; Conte C; Prudenzi E; Cacciatore I; Cornacchia C; Taha E; Pinnen F
Free Radic Biol Med; 2010 Jul; 49(1):31-9. PubMed ID: 20307650
[TBL] [Abstract][Full Text] [Related]
14. Reduction potentials of protein disulfides and catalysis of glutathionylation and deglutathionylation by glutaredoxin enzymes.
Ukuwela AA; Bush AI; Wedd AG; Xiao Z
Biochem J; 2017 Nov; 474(22):3799-3815. PubMed ID: 28963348
[TBL] [Abstract][Full Text] [Related]
15. L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room.
Paul R; Borah A
Biochim Biophys Acta; 2016 Sep; 1860(9):1989-97. PubMed ID: 27318154
[TBL] [Abstract][Full Text] [Related]
16. 17beta-estradiol induces protein thiol/disulfide oxidoreductases and protects cultured bovine aortic endothelial cells from oxidative stress.
Ejima K; Nanri H; Araki M; Uchida K; Kashimura M; Ikeda M
Eur J Endocrinol; 1999 Jun; 140(6):608-13. PubMed ID: 10366417
[TBL] [Abstract][Full Text] [Related]
17. Linked thioredoxin-glutathione systems in platyhelminth parasites: alternative pathways for glutathione reduction and deglutathionylation.
Bonilla M; Denicola A; Marino SM; Gladyshev VN; Salinas G
J Biol Chem; 2011 Feb; 286(7):4959-67. PubMed ID: 21051543
[TBL] [Abstract][Full Text] [Related]
18. l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?
Del-Bel E; Bortolanza M; Dos-Santos-Pereira M; Bariotto K; Raisman-Vozari R
Synapse; 2016 Dec; 70(12):479-500. PubMed ID: 27618286
[TBL] [Abstract][Full Text] [Related]
19. Conferring specificity in redox pathways by enzymatic thiol/disulfide exchange reactions.
Netto LE; de Oliveira MA; Tairum CA; da Silva Neto JF
Free Radic Res; 2016; 50(2):206-45. PubMed ID: 26573728
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
Abdin AA; Hamouda HE
Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
